整合基线协变量的贝叶斯方法借入历史对照数据:中性比较研究
针对罕见病和儿科试验中传统随机对照试验难以实施的问题,该研究对三种整合基线协变量的贝叶斯动态借入方法进行中性比较,包括倾向评分加权相称先验、倾向评分加权多源可交换性模型和贝叶斯加性回归树,通过模拟和两个真实试验数据评估连续结局表现并给出方法选择建议。
要点
- 三种整合基线协变量的贝叶斯动态借入方法在连续结局下表现存在差异。
- 部分方法存在潜在问题,选择需结合具体试验情境。
- 研究为真实随机对照试验中选择借入方法提供了推荐。
核心结论
- 三种整合基线协变量的贝叶斯动态借入方法在连续结局下表现不一,部分方法存在潜在问题,并给出了方法选择建议。
研究设计与样本
- 通过广泛模拟评估三种方法对连续结局的性能,并使用两个基于真实随机对照试验数据的例子进一步评价。
主要发现
- 研究揭示了部分整合基线协变量的贝叶斯动态借入方法存在潜在问题。
临床怎么用
- 为真实随机对照试验中选择特定的整合基线协变量的贝叶斯动态借入方法提供推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The idea of leveraging historical control data in randomized clinical trials (RCTs) has gained a lot of attention, in particular for rare disease and pediatric indications where conducting traditional and fully powered RCTs can be challenging. In this regard, Bayesian dynamic borrowing (BDB) methods, which adapt the amount of borrowing based on the outcome heterogeneity between the current and historical data, are well established. In recent years, an increasing number of related methods have been published that combine the BDB framework with approaches that account for baseline covariates. The underlying rationale is that some of the heterogeneity may be explained systematically by variations in the distributions of these characteristics. While many such methods are now available, direct comparisons of them are scarce and there is no consensus on which one can be considered the state of the art. We address this issue by conducting a neutral comparison of three methods of this class, namely the propensity score weighted commensurate prior, propensity score weighted multi-source exchangeability models, and Bayesian additive regression trees. We assess their performance for continuous outcomes through extensive simulations and further evaluate them using two examples based on real RCT data. Our study reveals potential issues with some of these approaches and provides recommendations for choosing a particular method for real RCTs.
引用
- Jesse D, Uschner D, Elze MC, et al. Bayesian Methods Incorporating Baseline Covariates for Borrowing Historical Control Data in Randomized Clinical Trials: A Neutral Comparison Study. Stat Med. 2026. PMID: 42914204. doi:10.1002/sim.70785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。